Menu

LIFR inhibition enhances the therapeutic efficacy of HDAC inhibitors in triple negative breast cancer

Article |

stonefox42 3mo ago
LIFR inhibition enhances the therapeutic efficacy of HDAC inhibitors in triple negative breast cancer

Histone deacetylase inhibitors (HDACi) are identified as novel therapeutic agents, however, recent clinical studies suggested that they are...

Comments (0)

Newest

No comments yet.